Identifying patients at risk of supratherapeutic amisulpride exposure in routine psychiatric practice: a real-world therapeutic drug monitoring study

Keyu Yan, Gehang Ju, Aowei Li, Ruomei Gao, Na Wang, Qing Shao

Open source

DOI
10.1177/20451253261460142
Published
2026-07
Container
Therapeutic Advances in Psychopharmacology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20451253261460142,
  title = {Identifying patients at risk of supratherapeutic amisulpride exposure in routine psychiatric practice: a real-world therapeutic drug monitoring study},
  author = {Keyu Yan and Gehang Ju and Aowei Li and Ruomei Gao and Na Wang and Qing Shao},
  year = {2026},
  journal = {Therapeutic Advances in Psychopharmacology},
  doi = {10.1177/20451253261460142},
  url = {https://doi.org/10.1177/20451253261460142}
}

RIS

TY  - JOUR
TI  - Identifying patients at risk of supratherapeutic amisulpride exposure in routine psychiatric practice: a real-world therapeutic drug monitoring study
AU  - Keyu Yan
AU  - Gehang Ju
AU  - Aowei Li
AU  - Ruomei Gao
AU  - Na Wang
AU  - Qing Shao
PY  - 2026
JO  - Therapeutic Advances in Psychopharmacology
DO  - 10.1177/20451253261460142
UR  - https://doi.org/10.1177/20451253261460142
ER  - 

APA

Yan, K., Ju, G., Li, A., Gao, R., Wang, N., & Shao, Q. (2026). Identifying patients at risk of supratherapeutic amisulpride exposure in routine psychiatric practice: a real-world therapeutic drug monitoring study. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/20451253261460142

Source records